AEON Biopharma, Inc. (AEON)
NYSEAMERICAN: AEON · Real-Time Price · USD
0.7768
-0.0232 (-2.91%)
Aug 14, 2025, 11:24 AM - Market open
AEON Biopharma Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
| Cash & Equivalents | 8.44 | 0.01 | 5.16 | 9.75 | 5.13 | 20.17 | Upgrade
|
| Cash & Short-Term Investments | 8.44 | 0.01 | 5.16 | 9.75 | 5.13 | 20.17 | Upgrade
|
| Cash Growth | 145.18% | -99.75% | -47.08% | 90.05% | -74.57% | -81.95% | Upgrade
|
| Prepaid Expenses | 1.82 | 1.58 | 1.06 | 0.09 | 0.03 | 0.21 | Upgrade
|
| Total Current Assets | 10.26 | 1.59 | 6.22 | 9.84 | 5.15 | 20.38 | Upgrade
|
| Property, Plant & Equipment | 1.37 | 1.52 | 0.59 | 0.91 | 0.92 | - | Upgrade
|
| Long-Term Deferred Charges | - | - | - | - | - | 0.84 | Upgrade
|
| Other Long-Term Assets | 0.03 | 0.03 | 0.03 | 0.03 | 0.36 | - | Upgrade
|
| Total Assets | 11.66 | 3.14 | 6.85 | 10.78 | 6.44 | 21.21 | Upgrade
|
| Accounts Payable | 3.91 | 5.91 | 3.39 | 7.81 | 1.19 | 2.03 | Upgrade
|
| Accrued Expenses | 5.22 | 8.12 | 9.38 | 3.65 | 4.01 | 2.17 | Upgrade
|
| Current Portion of Long-Term Debt | - | - | - | 70.87 | 15.6 | - | Upgrade
|
| Current Portion of Leases | - | 0.12 | 0.28 | 0.26 | - | - | Upgrade
|
| Total Current Liabilities | 9.13 | 14.15 | 13.05 | 82.57 | 20.8 | 4.2 | Upgrade
|
| Long-Term Debt | 15.17 | 11.69 | - | 60.43 | 70.76 | 72.16 | Upgrade
|
| Long-Term Leases | 1.02 | 1.15 | - | 0.24 | 0.52 | - | Upgrade
|
| Other Long-Term Liabilities | 2.19 | 4.73 | 146.84 | - | 0.22 | 10.14 | Upgrade
|
| Total Liabilities | 27.51 | 31.71 | 159.89 | 143.24 | 92.31 | 86.5 | Upgrade
|
| Common Stock | 0.01 | 0 | 0 | 0.01 | 0.01 | 0.01 | Upgrade
|
| Additional Paid-In Capital | 413.28 | 403.02 | 381.26 | 187.35 | 187.35 | 158.39 | Upgrade
|
| Retained Earnings | -429.14 | -431.6 | -473.6 | -474.84 | -422.28 | -366.65 | Upgrade
|
| Treasury Stock | - | - | - | -0.02 | -0.02 | -0.02 | Upgrade
|
| Comprehensive Income & Other | - | - | -60.71 | - | - | - | Upgrade
|
| Total Common Equity | -15.85 | -28.57 | -153.04 | -287.5 | -234.94 | -208.27 | Upgrade
|
| Minority Interest | - | - | - | 17.09 | 11.12 | 5.04 | Upgrade
|
| Shareholders' Equity | -15.85 | -28.57 | -153.04 | -132.46 | -85.88 | -65.29 | Upgrade
|
| Total Liabilities & Equity | 11.66 | 3.14 | 6.85 | 10.78 | 6.44 | 21.21 | Upgrade
|
| Total Debt | 16.19 | 12.96 | 0.28 | 131.79 | 86.89 | 72.16 | Upgrade
|
| Net Cash (Debt) | -7.76 | -12.94 | 4.88 | -122.05 | -81.76 | -51.99 | Upgrade
|
| Net Cash Per Share | -1.91 | -22.47 | 0.06 | -63.29 | -46.63 | -567.46 | Upgrade
|
| Filing Date Shares Outstanding | 11.64 | 10.53 | 0.55 | 1.93 | 1.93 | 0.11 | Upgrade
|
| Total Common Shares Outstanding | 11.54 | 0.56 | 0.52 | 1.93 | 1.93 | 0.09 | Upgrade
|
| Working Capital | 1.13 | -12.56 | -6.83 | -72.74 | -15.65 | 16.18 | Upgrade
|
| Book Value Per Share | -1.37 | -51.43 | -296.54 | -149.11 | -121.85 | -2273.18 | Upgrade
|
| Tangible Book Value | -15.85 | -28.57 | -153.04 | -287.5 | -234.94 | -208.27 | Upgrade
|
| Tangible Book Value Per Share | -1.37 | -51.43 | -296.54 | -149.11 | -121.85 | -2273.18 | Upgrade
|
| Machinery | - | 0.44 | 0.44 | 0.44 | 0.13 | - | Upgrade
|
| Leasehold Improvements | - | 0.07 | 0.07 | 0.07 | 0.07 | - | Upgrade
|
Updated May 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.